Document is current
Any future updates will be listed below
-
Authors
Ai, Liangxia
Li, Yafei
Zhou, Li https://orcid.org/0000-0002-6736-0057
Yao, Wenrong
Zhang, Hao
Hu, Zhaoyu
Han, Jinyu
Wang, Weijie
Wu, Junmiao
Xu, Pan
Wang, Ruiyue
Li, Zhangyi
Li, Zhouwang
Wei, Chengliang
Liang, Jianqun
Chen, Haobo
Yang, Zhimiao
Guo, Ming
Huang, Zhixiang
Wang, Xin
Zhang, Zhen
Xiang, Wenjie
Sun, Dazheng
Xu, Lianqiang
Huang, Meiyan
Lv, Bin
Peng, Peiqi
Zhang, Shangfeng
Ji, Xuhao
Luo, Huiyi
Chen, Nanping
Chen, Jianping
Lan, Ke https://orcid.org/0000-0002-0384-8598
Hu, Yong
- License Information
-
More Information
Article History
Received: 14 September 2022
Accepted: 28 December 2022
First Online: 23 January 2023
Competing interests
: Y.H., L.A., Y.L., and Rhegen Biotechnology are inventors of patents and patent applications related to RNA technology, lyophilization technology, and COVID-19 vaccines. Y.H., L.A., Y.L., H.Z., Z. Hu, J.H., J.W., H.C., J.L., Z.Y., R.W., Zhangyi L., Zhouwang L., W.W., D.S., M.H., P.X., B.L., P.P., S.Z., C.W., H.L., X.J., L.X., and N.C. are employees of Rhegen Biotechnology. J.C. and W.Y. are employees of Rec-biotechnology.
